<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun S</submitter><funding>Social Development and Scientific-technological Foundation of Zhenjiang</funding><pagination>1209-1219</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8265791</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(12)</volume><pubmed_abstract>Ankylosing spondylitis (AS) is a chronic autoimmune disease in which let-7i has been studied to involved. But, whether let-7i-3p could regulate osteoblast differentiation in AS remains unclear. This research targeted to decipher the impact of let-7i-3p on AS progression by modulating pyruvate dehydrogenase kinase 1 (PDK1). The bone mineral density of femur and lumbar vertebra and the maximum loading and bending elastic modulus of tibia, tumor necrosis factor-α (TNF-α), matrix metalloproteinase (MMP)-3, osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) in serum of AS mice, the pathological condition of synovial tissue were determined via let-7i-3p inhibitor and OE-PDK1 in animal experiment. Also, the cell viability and ALP activity were measured by let-7i-3p i</pubmed_abstract><journal>Cell cycle (Georgetown, Tex.)</journal><pubmed_title>MicroRNA let-7i-3p affects osteoblast differentiation in ankylosing spondylitis via targeting PDK1.</pubmed_title><pmcid>PMC8265791</pmcid><funding_grant_id>SH2018040</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Zhu Z</pubmed_authors><pubmed_authors>Sun S</pubmed_authors><pubmed_authors>Kong D</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA let-7i-3p affects osteoblast differentiation in ankylosing spondylitis via targeting PDK1.</name><description>Ankylosing spondylitis (AS) is a chronic autoimmune disease in which let-7i has been studied to involved. But, whether let-7i-3p could regulate osteoblast differentiation in AS remains unclear. This research targeted to decipher the impact of let-7i-3p on AS progression by modulating pyruvate dehydrogenase kinase 1 (PDK1). The bone mineral density of femur and lumbar vertebra and the maximum loading and bending elastic modulus of tibia, tumor necrosis factor-α (TNF-α), matrix metalloproteinase (MMP)-3, osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) in serum of AS mice, the pathological condition of synovial tissue were determined via let-7i-3p inhibitor and OE-PDK1 in animal experiment. Also, the cell viability and ALP activity were measured by let-7i-3p i</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2025-04-19T20:44:43.041Z</modification><creation>2025-04-19T20:44:43.041Z</creation></dates><accession>S-EPMC8265791</accession><cross_references><pubmed>34048311</pubmed><doi>10.1080/15384101.2021.1930680</doi></cross_references></HashMap>